· 2022–2024 · DOL EFAST2
Search
Browse
Resources
Pricing
NORTHERN PHARMACY & MEDICAL EQUI — NORTHERN PHARMACY & MEDICAL EQUIPMENT, INC. 401(K) PLAN, Form 5500 (2024) | Form 5500 Search
Back to filter
Original filing (PDF)
20250725052430NAL0006218625001
NORTHERN PHARMACY & MEDICAL EQUI
Form 5500-SF
FILING_RECEIVED
NORTHERN PHARMACY & MEDICAL EQUIPMENT, INC. 401(K) PLAN
401(k) retirement plan
Signals · 1
No auditor on file
Active participants
133
Accounts w/ balance
75
Plan assets (EOY)
$7.9M
Net assets (EOY)
$7.9M
Plan health score (directional)
74
/ 100
Grade B
Above-average plan
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
60
Concentration risk
75
Total plan cost
75
Vendor stack
100
Participation health
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for
NORTHERN PHARMACY & MEDICAL EQUI
.
Find decision makers
Plan sponsor
Name
NORTHERN PHARMACY & MEDICAL EQUI
EIN
52-1363631
Address
6701 HARFORD RD · BALTIMORE, MD · 21234
Phone
(410) 254-2055
Industry
Retail Trade
see all
Plan administrator
Same as plan sponsor.
Plan characteristics
Plan number
002
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-07-25
Pension benefit codes
2E · Profit-sharing
2F · ERISA section 404(c)
2G · Total participant-directed accounts
2J · 401(k) feature
2K · 401(m) arrangement
2T · Default investment account (QDIA)
3D · Pre-approved plan (master / prototype / VS)
Audit & trust (Schedule H)
Service providers (Schedule C)
Small plans don't disclose service providers
Related plans
Similar-size Retail Trade plans
JOLLYS PHARMACY, INC.
JOLLY'S PHARMACY INC. 401(K) PROFIT SHARING PLAN
$7.9M · 170 participants
DANIEL PHARMACY
DANIEL PHARMACY 401(K) PROFIT SHARING PLAN
$7.9M · 8 participants
B & K PRESCRIPTION SHOP, INC.
B & K PRESCRIPTION SHOP, INC. 401(K) PROFIT SHARING PLAN
$7.9M · 30 participants
SENDERRA RX PARTNERS LLC
SENDERRA RX PARTNERS LLC 401(K) PROFIT SHARING PLAN & TRUST
$7.9M · 284 participants
STONER DRUG COMPANY PROFIT SHARING PLAN
STONER DRUG COMPANY PROFIT SHARING PLAN
80
Knocking points off
No independent qualified public accountant (IQPA) named.
56% balance-to-active ratio — below typical for a healthy 401(k).
Helping the score
Concentration not scored — Schedule of Assets PDF not yet parsed for this plan.
No Schedule C compensation disclosed — likely a small plan or unbundled.
Auditor
—
Trustee / custodian
—
Trustee phone
—
Small plan (5500-SF) — Schedule H data not available.
$8.1M · 22 participants
T C FLYNN PHARMACY INC
T C FLYNN PHARMACY INC PROFIT SHARING PLAN
$7.8M · 40 participants
Large plans in Maryland
LOCKHEED MARTIN CORPORATION
LMC DEFINED CONTRIBUTION MASTER TRUST
$56.1B
LOCKHEED MARTIN CORPORATION
LOCKHEED MARTIN CORPORATION SALARIED SAVINGS PLAN
$51.4B · 94,445 participants
T. ROWE PRICE TRUST COMPANY
T. ROWE PRICE INSTITUTIONAL COMMON TRUST FUND, T. ROWE PRICE GROWTH STOCK TRUST
$36.0B
T. ROWE PRICE TRUST COMPANY
T.ROWE PRICE STRATEGIC COMMON TRUST FUND, T.ROWE PRICE RETIREMENT 2040 TRUST
$35.2B
T. ROWE PRICE TRUST COMPANY
T.ROWE PRICE STRATEGIC COMMON TRUST FUND, T.ROWE PRICE RETIREMENT 2030 TRUST
$35.0B
T. ROWE PRICE TRUST COMPANY
T.ROWE PRICE STRATEGIC COMMON TRUST FUND, T.ROWE PRICE U.S. VALUE EQUITY TRUST
$32.2B